Structure

Physi-Chem Properties

Molecular Weight:  218.13
Volume:  246.542
LogP:  3.352
LogD:  2.986
LogS:  -3.091
# Rotatable Bonds:  4
TPSA:  40.46
# H-Bond Aceptor:  2
# H-Bond Donor:  2
# Rings:  1
# Heavy Atoms:  2

MedChem Properties

QED Drug-Likeness Score:  0.763
Synthetic Accessibility Score:  2.564
Fsp3:  0.286
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.598
MDCK Permeability:  2.5319590349681675e-05
Pgp-inhibitor:  0.013
Pgp-substrate:  0.009
Human Intestinal Absorption (HIA):  0.007
20% Bioavailability (F20%):  0.195
30% Bioavailability (F30%):  0.901

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.92
Plasma Protein Binding (PPB):  95.9462661743164%
Volume Distribution (VD):  3.732
Pgp-substrate:  4.580868244171143%

ADMET: Metabolism

CYP1A2-inhibitor:  0.92
CYP1A2-substrate:  0.299
CYP2C19-inhibitor:  0.334
CYP2C19-substrate:  0.164
CYP2C9-inhibitor:  0.244
CYP2C9-substrate:  0.858
CYP2D6-inhibitor:  0.445
CYP2D6-substrate:  0.849
CYP3A4-inhibitor:  0.272
CYP3A4-substrate:  0.272

ADMET: Excretion

Clearance (CL):  16.039
Half-life (T1/2):  0.899

ADMET: Toxicity

hERG Blockers:  0.03
Human Hepatotoxicity (H-HT):  0.668
Drug-inuced Liver Injury (DILI):  0.034
AMES Toxicity:  0.045
Rat Oral Acute Toxicity:  0.052
Maximum Recommended Daily Dose:  0.408
Skin Sensitization:  0.947
Carcinogencity:  0.372
Eye Corrosion:  0.05
Eye Irritation:  0.967
Respiratory Toxicity:  0.31

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC128723

Natural Product ID:  NPC128723
Common Name*:   4-Hydroxy-3-(3-Methyl-2-Butenyl)Cinnamyl Alcohol
IUPAC Name:   4-[(E)-3-hydroxyprop-1-enyl]-2-(3-methylbut-2-enyl)phenol
Synonyms:  
Standard InCHIKey:  UJHVAGVJXNRBBS-ONEGZZNKSA-N
Standard InCHI:  InChI=1S/C14H18O2/c1-11(2)5-7-13-10-12(4-3-9-15)6-8-14(13)16/h3-6,8,10,15-16H,7,9H2,1-2H3/b4-3+
SMILES:  OC/C=C/c1ccc(c(c1)CC=C(C)C)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL252311
PubChem CID:   6440309
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002754] Cinnamyl alcohols

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO21390 Zanthoxylum integrifoliolum Species Rutaceae Eukaryota fruit Lanyu Island, Taitung County, Taiwan n.a. PMID[10395498]
NPO21390 Zanthoxylum integrifoliolum Species Rutaceae Eukaryota n.a. n.a. n.a. PMID[17822293]
NPO21390 Zanthoxylum integrifoliolum Species Rutaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO21390 Zanthoxylum integrifoliolum Species Rutaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2740 Cell Line Neutrophils IC50 = 75140.0 nM PMID[526258]
NPT566 Organism Salmonella typhimurium Salmonella enterica subsp. enterica serovar Typhimurium Inhibition = 20.2 % PMID[526259]
NPT566 Organism Salmonella typhimurium Salmonella enterica subsp. enterica serovar Typhimurium Inhibition = 27.1 % PMID[526259]
NPT566 Organism Salmonella typhimurium Salmonella enterica subsp. enterica serovar Typhimurium Inhibition = 36.8 % PMID[526259]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC128723 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9348 High Similarity NPC204210
0.9263 High Similarity NPC77492
0.9255 High Similarity NPC8392
0.9247 High Similarity NPC138117
0.9247 High Similarity NPC325292
0.9239 High Similarity NPC300017
0.9167 High Similarity NPC122005
0.9167 High Similarity NPC252821
0.913 High Similarity NPC242240
0.913 High Similarity NPC70436
0.913 High Similarity NPC123273
0.913 High Similarity NPC318325
0.9072 High Similarity NPC225506
0.9053 High Similarity NPC313650
0.9053 High Similarity NPC144682
0.9022 High Similarity NPC25493
0.9022 High Similarity NPC104216
0.9022 High Similarity NPC113460
0.901 High Similarity NPC262365
0.8969 High Similarity NPC51333
0.8969 High Similarity NPC78119
0.8969 High Similarity NPC216468
0.8969 High Similarity NPC132078
0.8947 High Similarity NPC128062
0.8947 High Similarity NPC289769
0.8925 High Similarity NPC258219
0.8925 High Similarity NPC280347
0.8925 High Similarity NPC177420
0.8913 High Similarity NPC407
0.8913 High Similarity NPC307235
0.8913 High Similarity NPC23167
0.89 High Similarity NPC303141
0.89 High Similarity NPC138942
0.8889 High Similarity NPC235762
0.8889 High Similarity NPC471228
0.8889 High Similarity NPC168829
0.8878 High Similarity NPC213730
0.8878 High Similarity NPC174911
0.8866 High Similarity NPC474073
0.8854 High Similarity NPC26244
0.8846 High Similarity NPC228425
0.8835 High Similarity NPC44732
0.883 High Similarity NPC47950
0.883 High Similarity NPC300478
0.883 High Similarity NPC55561
0.8804 High Similarity NPC155393
0.8804 High Similarity NPC197783
0.88 High Similarity NPC475225
0.88 High Similarity NPC288411
0.8788 High Similarity NPC91461
0.8788 High Similarity NPC7686
0.8788 High Similarity NPC40258
0.8763 High Similarity NPC473388
0.875 High Similarity NPC27323
0.875 High Similarity NPC308689
0.875 High Similarity NPC316301
0.875 High Similarity NPC152415
0.875 High Similarity NPC151715
0.8738 High Similarity NPC75272
0.8738 High Similarity NPC471954
0.8737 High Similarity NPC45040
0.8737 High Similarity NPC304541
0.8737 High Similarity NPC306074
0.8725 High Similarity NPC228737
0.8713 High Similarity NPC154899
0.8713 High Similarity NPC243677
0.8713 High Similarity NPC233396
0.871 High Similarity NPC184169
0.87 High Similarity NPC470202
0.87 High Similarity NPC108497
0.8696 High Similarity NPC286904
0.8696 High Similarity NPC175313
0.8696 High Similarity NPC248817
0.8679 High Similarity NPC12656
0.8641 High Similarity NPC63698
0.8641 High Similarity NPC61885
0.8627 High Similarity NPC92623
0.8627 High Similarity NPC135464
0.8627 High Similarity NPC271274
0.86 High Similarity NPC471578
0.86 High Similarity NPC101025
0.8598 High Similarity NPC474486
0.8587 High Similarity NPC265146
0.8587 High Similarity NPC124436
0.8586 High Similarity NPC80027
0.8586 High Similarity NPC92730
0.8544 High Similarity NPC66834
0.8542 High Similarity NPC155908
0.8542 High Similarity NPC270547
0.8529 High Similarity NPC99557
0.8529 High Similarity NPC219286
0.8526 High Similarity NPC98772
0.8515 High Similarity NPC269212
0.8505 High Similarity NPC473137
0.8505 High Similarity NPC268160
0.85 High Similarity NPC130103
0.85 High Similarity NPC48730
0.85 High Similarity NPC72729
0.85 High Similarity NPC294741
0.85 High Similarity NPC129373
0.85 High Similarity NPC211885
0.85 High Similarity NPC248396
0.8491 Intermediate Similarity NPC228988
0.8491 Intermediate Similarity NPC302371
0.8485 Intermediate Similarity NPC6597
0.8485 Intermediate Similarity NPC152097
0.8485 Intermediate Similarity NPC79241
0.8485 Intermediate Similarity NPC225464
0.8476 Intermediate Similarity NPC296683
0.8476 Intermediate Similarity NPC132720
0.8476 Intermediate Similarity NPC475018
0.8469 Intermediate Similarity NPC274678
0.8469 Intermediate Similarity NPC222146
0.8462 Intermediate Similarity NPC470039
0.8462 Intermediate Similarity NPC317305
0.8454 Intermediate Similarity NPC271440
0.8454 Intermediate Similarity NPC306884
0.8454 Intermediate Similarity NPC94139
0.8454 Intermediate Similarity NPC3358
0.8454 Intermediate Similarity NPC210497
0.8454 Intermediate Similarity NPC147284
0.8454 Intermediate Similarity NPC162314
0.8447 Intermediate Similarity NPC21594
0.8447 Intermediate Similarity NPC54765
0.844 Intermediate Similarity NPC477136
0.8438 Intermediate Similarity NPC312304
0.8438 Intermediate Similarity NPC192
0.8431 Intermediate Similarity NPC119860
0.8426 Intermediate Similarity NPC192948
0.8426 Intermediate Similarity NPC35797
0.8426 Intermediate Similarity NPC147179
0.8421 Intermediate Similarity NPC19680
0.8421 Intermediate Similarity NPC27974
0.8416 Intermediate Similarity NPC110764
0.8416 Intermediate Similarity NPC51015
0.8411 Intermediate Similarity NPC35344
0.8411 Intermediate Similarity NPC141003
0.84 Intermediate Similarity NPC33675
0.84 Intermediate Similarity NPC299762
0.84 Intermediate Similarity NPC100870
0.84 Intermediate Similarity NPC260775
0.8396 Intermediate Similarity NPC95716
0.8396 Intermediate Similarity NPC225679
0.8396 Intermediate Similarity NPC165770
0.8396 Intermediate Similarity NPC4493
0.8396 Intermediate Similarity NPC476632
0.8384 Intermediate Similarity NPC259512
0.8384 Intermediate Similarity NPC292730
0.8384 Intermediate Similarity NPC132271
0.8384 Intermediate Similarity NPC82664
0.8384 Intermediate Similarity NPC216520
0.8384 Intermediate Similarity NPC283711
0.8384 Intermediate Similarity NPC312132
0.8381 Intermediate Similarity NPC58865
0.8381 Intermediate Similarity NPC473524
0.8367 Intermediate Similarity NPC245187
0.8365 Intermediate Similarity NPC151477
0.8351 Intermediate Similarity NPC231150
0.835 Intermediate Similarity NPC474839
0.835 Intermediate Similarity NPC471350
0.8349 Intermediate Similarity NPC477137
0.8349 Intermediate Similarity NPC38893
0.8349 Intermediate Similarity NPC308828
0.8349 Intermediate Similarity NPC219112
0.8349 Intermediate Similarity NPC308311
0.8333 Intermediate Similarity NPC62351
0.8318 Intermediate Similarity NPC43525
0.8318 Intermediate Similarity NPC473521
0.8318 Intermediate Similarity NPC46940
0.8317 Intermediate Similarity NPC12931
0.8317 Intermediate Similarity NPC70677
0.8317 Intermediate Similarity NPC130756
0.8302 Intermediate Similarity NPC13482
0.8302 Intermediate Similarity NPC63345
0.83 Intermediate Similarity NPC475078
0.83 Intermediate Similarity NPC88420
0.83 Intermediate Similarity NPC260000
0.8288 Intermediate Similarity NPC473767
0.8288 Intermediate Similarity NPC151197
0.8286 Intermediate Similarity NPC95344
0.8283 Intermediate Similarity NPC286006
0.828 Intermediate Similarity NPC304538
0.8273 Intermediate Similarity NPC304510
0.8273 Intermediate Similarity NPC172219
0.8269 Intermediate Similarity NPC113457
0.8269 Intermediate Similarity NPC469913
0.8265 Intermediate Similarity NPC55903
0.8265 Intermediate Similarity NPC29373
0.8265 Intermediate Similarity NPC181709
0.8252 Intermediate Similarity NPC108875
0.8252 Intermediate Similarity NPC12278
0.8252 Intermediate Similarity NPC323810
0.8252 Intermediate Similarity NPC272029
0.8252 Intermediate Similarity NPC38079
0.8241 Intermediate Similarity NPC242136
0.8241 Intermediate Similarity NPC117846
0.8241 Intermediate Similarity NPC28784
0.8241 Intermediate Similarity NPC296144
0.8235 Intermediate Similarity NPC252105
0.8235 Intermediate Similarity NPC477685

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC128723 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9053 High Similarity NPD1809 Phase 2
0.9043 High Similarity NPD845 Approved
0.8854 High Similarity NPD2859 Approved
0.8854 High Similarity NPD2860 Approved
0.8788 High Similarity NPD846 Approved
0.8788 High Similarity NPD940 Approved
0.875 High Similarity NPD1432 Clinical (unspecified phase)
0.875 High Similarity NPD2934 Approved
0.875 High Similarity NPD2933 Approved
0.866 High Similarity NPD844 Approved
0.8587 High Similarity NPD111 Approved
0.8586 High Similarity NPD3020 Approved
0.8396 Intermediate Similarity NPD6124 Clinical (unspecified phase)
0.8384 Intermediate Similarity NPD288 Approved
0.8317 Intermediate Similarity NPD289 Clinical (unspecified phase)
0.8241 Intermediate Similarity NPD7159 Clinical (unspecified phase)
0.7944 Intermediate Similarity NPD2684 Approved
0.7876 Intermediate Similarity NPD3091 Approved
0.787 Intermediate Similarity NPD3021 Approved
0.787 Intermediate Similarity NPD9380 Clinical (unspecified phase)
0.787 Intermediate Similarity NPD3022 Approved
0.7818 Intermediate Similarity NPD7635 Approved
0.7797 Intermediate Similarity NPD1131 Approved
0.7797 Intermediate Similarity NPD1133 Approved
0.7797 Intermediate Similarity NPD1129 Approved
0.7797 Intermediate Similarity NPD1135 Approved
0.7797 Intermediate Similarity NPD1134 Approved
0.7736 Intermediate Similarity NPD9610 Approved
0.7736 Intermediate Similarity NPD9608 Approved
0.7719 Intermediate Similarity NPD5303 Approved
0.7719 Intermediate Similarity NPD5304 Approved
0.7717 Intermediate Similarity NPD9294 Approved
0.7706 Intermediate Similarity NPD4750 Phase 3
0.7685 Intermediate Similarity NPD2342 Discontinued
0.7685 Intermediate Similarity NPD290 Approved
0.7658 Intermediate Similarity NPD7843 Approved
0.7632 Intermediate Similarity NPD16 Approved
0.7632 Intermediate Similarity NPD856 Approved
0.7627 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD3028 Approved
0.7619 Intermediate Similarity NPD1242 Phase 1
0.7607 Intermediate Similarity NPD3092 Approved
0.7596 Intermediate Similarity NPD9273 Approved
0.7593 Intermediate Similarity NPD1445 Approved
0.7593 Intermediate Similarity NPD1444 Approved
0.7589 Intermediate Similarity NPD2229 Approved
0.7589 Intermediate Similarity NPD2228 Approved
0.7589 Intermediate Similarity NPD2234 Approved
0.7586 Intermediate Similarity NPD4626 Approved
0.7586 Intermediate Similarity NPD4589 Approved
0.7586 Intermediate Similarity NPD5238 Clinical (unspecified phase)
0.7568 Intermediate Similarity NPD228 Approved
0.75 Intermediate Similarity NPD821 Approved
0.75 Intermediate Similarity NPD4235 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7478 Intermediate Similarity NPD318 Approved
0.7478 Intermediate Similarity NPD317 Approved
0.7477 Intermediate Similarity NPD9500 Approved
0.7456 Intermediate Similarity NPD6671 Approved
0.7456 Intermediate Similarity NPD7157 Approved
0.7438 Intermediate Similarity NPD3690 Phase 2
0.7438 Intermediate Similarity NPD3691 Phase 2
0.7436 Intermediate Similarity NPD3095 Discontinued
0.7431 Intermediate Similarity NPD968 Approved
0.7414 Intermediate Similarity NPD1548 Phase 1
0.7391 Intermediate Similarity NPD9087 Approved
0.7387 Intermediate Similarity NPD1792 Phase 2
0.7373 Intermediate Similarity NPD3143 Discontinued
0.7368 Intermediate Similarity NPD9618 Approved
0.7368 Intermediate Similarity NPD9614 Approved
0.7355 Intermediate Similarity NPD3094 Phase 2
0.735 Intermediate Similarity NPD5691 Approved
0.7345 Intermediate Similarity NPD1138 Approved
0.7339 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD4659 Approved
0.7315 Intermediate Similarity NPD5700 Clinical (unspecified phase)
0.7311 Intermediate Similarity NPD1610 Phase 2
0.7304 Intermediate Similarity NPD256 Approved
0.7304 Intermediate Similarity NPD255 Approved
0.7288 Intermediate Similarity NPD3019 Approved
0.7288 Intermediate Similarity NPD2932 Approved
0.7288 Intermediate Similarity NPD4059 Approved
0.728 Intermediate Similarity NPD6407 Approved
0.728 Intermediate Similarity NPD6405 Approved
0.7265 Intermediate Similarity NPD7330 Discontinued
0.7263 Intermediate Similarity NPD9088 Approved
0.7257 Intermediate Similarity NPD1139 Approved
0.7257 Intermediate Similarity NPD1137 Approved
0.725 Intermediate Similarity NPD3070 Discontinued
0.725 Intermediate Similarity NPD2561 Approved
0.725 Intermediate Similarity NPD2562 Approved
0.7241 Intermediate Similarity NPD7325 Clinical (unspecified phase)
0.7236 Intermediate Similarity NPD4208 Discontinued
0.7232 Intermediate Similarity NPD5451 Approved
0.7227 Intermediate Similarity NPD2688 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD4060 Phase 1
0.7217 Intermediate Similarity NPD1476 Clinical (unspecified phase)
0.7213 Intermediate Similarity NPD4104 Clinical (unspecified phase)
0.7213 Intermediate Similarity NPD4103 Phase 2
0.7203 Intermediate Similarity NPD4093 Discontinued
0.7193 Intermediate Similarity NPD9379 Approved
0.7193 Intermediate Similarity NPD9377 Approved
0.719 Intermediate Similarity NPD6583 Phase 3
0.719 Intermediate Similarity NPD6582 Phase 2
0.7188 Intermediate Similarity NPD3553 Approved
0.7188 Intermediate Similarity NPD3552 Approved
0.7188 Intermediate Similarity NPD3554 Approved
0.7188 Intermediate Similarity NPD3555 Approved
0.7179 Intermediate Similarity NPD9613 Approved
0.7179 Intermediate Similarity NPD9615 Approved
0.7179 Intermediate Similarity NPD9616 Approved
0.7177 Intermediate Similarity NPD4908 Phase 1
0.7167 Intermediate Similarity NPD5351 Clinical (unspecified phase)
0.7167 Intermediate Similarity NPD5350 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD9384 Approved
0.7143 Intermediate Similarity NPD2286 Discontinued
0.7143 Intermediate Similarity NPD9381 Approved
0.7143 Intermediate Similarity NPD1751 Approved
0.7131 Intermediate Similarity NPD8651 Approved
0.7119 Intermediate Similarity NPD9545 Approved
0.7119 Intermediate Similarity NPD316 Approved
0.7117 Intermediate Similarity NPD3134 Approved
0.7097 Intermediate Similarity NPD2861 Phase 2
0.7097 Intermediate Similarity NPD5736 Approved
0.7094 Intermediate Similarity NPD7636 Approved
0.7094 Intermediate Similarity NPD9493 Approved
0.7083 Intermediate Similarity NPD3421 Phase 3
0.7073 Intermediate Similarity NPD1164 Approved
0.7069 Intermediate Similarity NPD1793 Approved
0.7069 Intermediate Similarity NPD475 Phase 2
0.7069 Intermediate Similarity NPD497 Approved
0.7069 Intermediate Similarity NPD1791 Approved
0.7059 Intermediate Similarity NPD1357 Approved
0.7054 Intermediate Similarity NPD1358 Approved
0.7054 Intermediate Similarity NPD9265 Clinical (unspecified phase)
0.7049 Intermediate Similarity NPD3685 Discontinued
0.7049 Intermediate Similarity NPD9622 Approved
0.704 Intermediate Similarity NPD4207 Discontinued
0.7025 Intermediate Similarity NPD422 Phase 1
0.7016 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7016 Intermediate Similarity NPD6584 Phase 3
0.7 Intermediate Similarity NPD6516 Phase 2
0.7 Intermediate Similarity NPD2667 Approved
0.7 Intermediate Similarity NPD2668 Approved
0.7 Intermediate Similarity NPD5846 Approved
0.6991 Remote Similarity NPD74 Approved
0.6991 Remote Similarity NPD9266 Approved
0.699 Remote Similarity NPD9295 Approved
0.6984 Remote Similarity NPD3027 Phase 3
0.6983 Remote Similarity NPD498 Approved
0.6983 Remote Similarity NPD495 Approved
0.6983 Remote Similarity NPD496 Approved
0.6983 Remote Similarity NPD594 Approved
0.6983 Remote Similarity NPD592 Approved
0.6983 Remote Similarity NPD4869 Clinical (unspecified phase)
0.6983 Remote Similarity NPD5283 Phase 1
0.6975 Remote Similarity NPD2226 Clinical (unspecified phase)
0.6975 Remote Similarity NPD1759 Phase 1
0.697 Remote Similarity NPD9089 Approved
0.696 Remote Similarity NPD4212 Discontinued
0.6952 Remote Similarity NPD159 Clinical (unspecified phase)
0.6949 Remote Similarity NPD9568 Approved
0.6944 Remote Similarity NPD9611 Approved
0.6944 Remote Similarity NPD9612 Approved
0.6944 Remote Similarity NPD9495 Approved
0.6944 Remote Similarity NPD9609 Approved
0.6942 Remote Similarity NPD3496 Discontinued
0.6942 Remote Similarity NPD3847 Discontinued
0.6929 Remote Similarity NPD6410 Clinical (unspecified phase)
0.6917 Remote Similarity NPD1651 Approved
0.6911 Remote Similarity NPD1669 Approved
0.6909 Remote Similarity NPD854 Approved
0.6909 Remote Similarity NPD855 Approved
0.6903 Remote Similarity NPD9267 Approved
0.6903 Remote Similarity NPD9264 Approved
0.6903 Remote Similarity NPD9263 Approved
0.6897 Remote Similarity NPD5535 Approved
0.6891 Remote Similarity NPD1758 Phase 1
0.6885 Remote Similarity NPD1201 Approved
0.6885 Remote Similarity NPD1091 Approved
0.688 Remote Similarity NPD9621 Approved
0.688 Remote Similarity NPD9620 Approved
0.688 Remote Similarity NPD9619 Approved
0.6875 Remote Similarity NPD6663 Approved
0.687 Remote Similarity NPD9280 Clinical (unspecified phase)
0.6869 Remote Similarity NPD9093 Approved
0.6864 Remote Similarity NPD6387 Discontinued
0.6864 Remote Similarity NPD2557 Approved
0.686 Remote Similarity NPD1778 Approved
0.6855 Remote Similarity NPD1283 Approved
0.6855 Remote Similarity NPD6696 Suspended
0.685 Remote Similarity NPD3136 Phase 2
0.685 Remote Similarity NPD4625 Phase 3
0.6846 Remote Similarity NPD4097 Suspended
0.6846 Remote Similarity NPD2157 Approved
0.6838 Remote Similarity NPD1398 Phase 1
0.6838 Remote Similarity NPD1241 Discontinued
0.6829 Remote Similarity NPD2230 Approved
0.6829 Remote Similarity NPD2233 Approved
0.6829 Remote Similarity NPD2232 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data